ArticleJournal of pharmaceutical analysis2025

Unlocking the potential of atractylenolide II: Mitigating non-alcoholic fatty liver disease through farnesoid X receptor-endoplasmic reticulum stress interplay.

Ming Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.